This COVID-19 roundup includes coverage of the FDA’s guidance for the correct Moderna vaccine dosage for pediatric patients, COVID-19 outcomes for patients with hypertension and diabetes, and the risk of...
The US Preventive Task Force (USPSTF) expanded upon their previous recommendations on screening for hypertensive disorders, including gestational hypertension, in patients who are pregnant.
Using a systematic review, researchers evaluated the use of low-dose combination triple and quadruple antihypertensives to manage hypertension in patients.
Researchers investigated the association and the potential sex differences between hypertension and blood pressure in early adulthood (ages 30-40 years) with late-life brain health.
According to a study, pregnant women without a previous diagnosis of hypertension developed postpartum hypertension—some more than 6 weeks after delivery.
Researchers performed a systematic review and meta-analyses to better understand the relationship between antihypertensive agent use and the risk of Alzheimer disease development.
The researchers observed trends in cardiovascular disease risk profiles across various populations to better understand the impact of secondary prevention resources.
In a recent study, researchers compared the impact of more intensive blood pressure treatment with standard treatment for stroke prevention in older adults.
